Sauna-Aho Oili, Bjelogrlic-Laakso Nina, Siren Auli, Arvio Maria
KTO-Special Welfare District of Varsinais-Suomi, Paimio, Finland.
Departments of Child Neurology and Public Health, University of Turku, Turku, Finland.
Mol Genet Genomic Med. 2018 Sep;6(5):855-860. doi: 10.1002/mgg3.430. Epub 2018 Jul 3.
Intellectual disability (ID) and dementia reflect disturbed cortical function during and after developmental age, respectively. Due to the wide heterogeneity of ID population the decline in cognitive and adaptive skills may be different in distinct genetic subgroups.
Using the British Present Psychiatric State-learning Disabilities assessment (PPS-LD) questionnaire the dementia signs were screened in 62, 22 and 44 individuals (> 35 year of age) with Down (DS, OMIM number 190685), Williams (WS, OMIM number, 194050), and Fragile X syndrome (FXS, OMIM number 309550), respectively. The median age of those with FXS (59 years) was higher than of those with DS (50 years) and WS (53 years).
Most study participants with DS (80%) and FXS (89%) were or had been moderately or severely intellectually disabled while most participants with WS (73%) were or had been mildly or moderately disabled at adolescent age. The adolescent (premorbid) level of ID did not correlate with the dementia score. The median scores were 11/27, 1/27, and 0/27 in DS, WS, and FXS subgroups, respectively. Dementia that was confirmed by brain imaging, manifested as Alzheimer disease and as moya-moya disease associated vascular dementia in DS and as vascular dementia in WS.
This survey suggests that the risk of dementia varies depending on the cause of ID and that the severity of ID in adolescence does not predict the development of dementia at a later age. Consequently, the ID and dementia should be understood as separate clinical entities that need to be taken into account in the health management of intellectually disabled people. This is important for the arrangement of appropriate and timely interventions, which can be expected to delay the need for institutionalization.
智力残疾(ID)和痴呆分别反映了发育年龄期间及之后的皮质功能紊乱。由于ID人群的广泛异质性,不同基因亚组的认知和适应技能下降情况可能有所不同。
使用英国当前精神状态 - 学习障碍评估(PPS - LD)问卷,分别对62名、22名和44名年龄大于35岁的唐氏综合征(DS,OMIM编号190685)、威廉姆斯综合征(WS,OMIM编号194050)和脆性X综合征(FXS,OMIM编号309550)患者进行痴呆体征筛查。FXS患者的中位年龄(59岁)高于DS患者(50岁)和WS患者(53岁)。
大多数DS患者(80%)和FXS患者(89%)曾有或目前仍为中度或重度智力残疾,而大多数WS患者(73%)在青少年时期曾有或目前仍为轻度或中度残疾。青少年期(病前)的ID水平与痴呆评分无关。DS、WS和FXS亚组的中位评分分别为11/27、1/27和0/27。经脑成像确诊的痴呆,在DS中表现为阿尔茨海默病和与烟雾病相关的血管性痴呆,在WS中表现为血管性痴呆。
这项调查表明,痴呆风险因ID病因而异,青少年期ID的严重程度不能预测晚年痴呆的发生。因此,ID和痴呆应被视为需要在智力残疾者健康管理中加以考虑的独立临床实体。这对于安排适当及时的干预措施很重要,有望推迟机构收容的需求。